Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion ...

Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...

The E1.S edge server SSD offers exceptional performance, reliability, and thermal management capabilities to address the ...

The data presented from these models provide a strong rationale for soquelitinib and our next-generation ITK inhibitors to be evaluated ... and the Company undertakes no obligation to update or revise ...

Goh Choon Phong, CEO, SIA, said that over the past six years, the airline engaged customers and stakeholders to help design ...

The partnership advances EA SPORTS commitment to grow and authentically represent women’s sports within its ...

DeepL, a leading global Language AI company, today announced the launch of its first voice translation solution DeepL Voice, ...

Infosys Knowledge Institute, a research arm of Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in ...

China's second fifth-generation stealth fighter jet is making a debut at its largest air show, taking centre stage at the ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 billion in ...

It is now imperative for life science companies to optimize Regulatory Affairs resources using next-generation technology if they are to ensure affordable patient access to treatments and achieve ...